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Abstract
Introduction: Contemporary information on mechanical ventilation (MV) use in emerging countries is limited.
Moreover, most epidemiological studies on ventilatory support were carried out before significant developments,
such as lung protective ventilation or broader application of non-invasive ventilation (NIV). We aimed to evaluate
the clinical characteristics, outcomes and risk factors for hospital mortality and failure of NIV in patients requiring
ventilatory support in Brazilian intensive care units (ICU).
Methods: In a multicenter, prospective, cohort study, a total of 773 adult patients admitted to 45 ICUs over a two-
month period requiring invasive ventilation or NIV for more than 24 hours were evaluated. Causes of ventilatory
support, prior chronic health status and physiological data were assessed. Multivariate analysis was used to identifiy
variables associated with hospital mortality and NIV failure.
Results: Invasive MV and NIV were used as initial ventilatory support in 622 (80%) and 151 (20%) patients. Failure
with subsequent intubation occurred in 54% of NIV patients. The main reasons for ventilatory support were
pneumonia (27%), neurologic disorders (19%) and non-pulmonary sepsis (12%). ICU and hospital mortality rates
were 34% and 42%. Using the Berlin definition, acute respiratory distress syndrome (ARDS) was diagnosed in 31%
of the patients with a hospital mortality of 52%. In the multivariate analysis, age (odds ratio (OR), 1.03; 95%
confidence interval (CI), 1.01 to 1.03), comorbidities (OR, 2.30; 95% CI, 1.28 to 3.17), associated organ failures (OR,
1.12; 95% CI, 1.05 to 1.20), moderate (OR, 1.92; 95% CI, 1.10 to 3.35) to severe ARDS (OR, 2.12; 95% CI, 1.01 to 4.41),
cumulative fluid balance over the first 72 h of ICU (OR, 2.44; 95% CI, 1.39 to 4.28), higher lactate (OR, 1.78; 95% CI,
1.27 to 2.50), invasive MV (OR, 2.67; 95% CI, 1.32 to 5.39) and NIV failure (OR, 3.95; 95% CI, 1.74 to 8.99) were
independently associated with hospital mortality. The predictors of NIV failure were the severity of associated organ
dysfunctions (OR, 1.20; 95% CI, 1.05 to 1.34), ARDS (OR, 2.31; 95% CI, 1.10 to 4.82) and positive fluid balance (OR,
2.09; 95% CI, 1.02 to 4.30).
Conclusions: Current mortality of ventilated patients in Brazil is elevated. Implementation of judicious fluid therapy
and a watchful use and monitoring of NIV patients are potential targets to improve outcomes in this setting.
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Introduction
Acute respiratory failure is frequent and commonly a
severe organ dysfunction occurring in the intensive care
unit (ICU) [1]. Under this circumstance, invasive or non-
invasive mechanical ventilation (MV) are life-sustaining
interventions [2]. However, despite significant advances in
ventilatory support [3], it remains associated with elevated
mortality [4] and a significant impairment in the patients’
quality of life in the post-ICU setting [5]. Therefore, infor-
mation about the epidemiological aspects of patients
under MV is important from both clinical and health pol-
icy perspectives. However, most studies on the epidemiol-
ogy of ventilatory support are outdated or were carried
out before significant developments in the field, such as
lung protective ventilation [6] or the widespread applica-
tion of non-invasive mechanical ventilation (NIV) [7-9].
Moreover, these studies were usually carried out in high-
income countries and very few contemporary data from
emerging countries are available [10-12]. Specifically from
Brazil, a previous trial evaluated the mortality of patients
with acute respiratory failure. However, this study was a
single center trial carried out only in a tertiary hospital
and just included individuals with invasive mechanical
ventilation and not patients under NIV [11]. Comprehen-
sive information about the clinical characteristics, out-
comes and risk factors for mortality of these patients is
essential to assist clinicians in the decision-making process
and to allow better resource allocation. Therefore, we
carried out a multicenter, observational cohort study in
Brazilian ICUs to describe the clinical outcomes of
patients submitted to ventilatory support as well as to
identify variables associated with hospital mortality.
Materials and methods
Design and setting
The Epidemiology of Respiratory Insufficiency in Criti-
cal Care (ERICC) study was a multicenter prospective
cohort study conducted in 45 Brazilian ICUs between 1
June 2011 and 31 July 2011. The study was coordinated
by the Research and Education Institute from Hospital
Sírio-Libanês, São Paulo and D’Or Institute for Research
and Education, Rio de Janeiro. Invitations were sent to
ICUs registered at the Brazilian Research in Intensive
Care Network (BRICNet) database and 45 ICUs from 12
Brazilian states agreed to participate. Investigators and
centers are listed at the acknowledgements section. The
study was strictly observational and decisions related to
patients’ care were at the discretion of the attending
ICU team. The study was approved by the institutional
review board (IRB) at the coordinating center (Comitê
de Ética em Pesquisa - CEPesq - approval number HSL
2010/51) and, subsequently, by the National Ethics
Committee and local review boards at each participating
site. The need for informed consent was waived or
requested in some sites according to the local IRBs
directives.
Selection of participants and definitions
Patients aged ≥ 18 years old requiring ventilatory support
for > 24 h during the first 48 h of ICU admission at the
participating ICUs were included in the study. In the sub-
group of patients undergoing NIV, only those that used
this modality for at least 6 h/day were included. Patients
with a previous tracheostomy, admitted for routine
uncomplicated postoperative care (ICU stay < 48 h), read-
missions and those with terminal conditions were not
considered.
Demographic, clinical and laboratory data were col-
lected during the ICU stay, including the main diagnosis
for ICU admission, the reasons for and modality of venti-
latory support (conventional MV or NIV), chronic health
status, the Charlson Comorbidity Index [13], the need for
vasopressors, dialysis, tracheostomy, the Simplified Acute
Physiology Score 3 (SAPS 3) [14] and the Sequential
Organ Failure Assessment (SOFA) score [15]. Patients
who first received NIV, irrespective of its duration, and
subsequently required endotracheal intubation were con-
sidered as NIV failure. The cumulative fluid balance over
the first 72 h of ICU stay was also calculated. Sepsis was
diagnosed using the current definitions [16]. The patient
was considered to have an infection when there were
clinical, laboratory, radiological and microbiological find-
ings suggesting the presence of infection that justified the
administration of antibiotics (excluding prophylaxis) [17].
Acute respiratory distress syndrome (ARDS) was defined
and classified according to the Berlin definition [18]. The
main outcome of interest in the current study was all
cause in-hospital mortality.
Data entry and processing
Data were collected using a web-based specific and stan-
dardized electronic case report form. Each investigator
and research coordinator was provided access to the web-
site, where all study documentation, including a compre-
hensive manual describing data collection requirements
and variable definitions, was available. A central office was
accessible through telephone and email contact to provide
support to investigators. Local investigators were responsi-
ble for training local staff for data collection, supervising
data collection, controlling for data completeness and
quality.
Data consistency was assessed through a rechecking
procedure of a 5% random sample of patients. Data
were screened in detail by three investigators (LCA, MS,
MP) for missing information, implausible and outlying
values, logical errors and insufficient details. In case of
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unconformity, local investigators were contacted to pro-
vide the requested information.
Statistical analysis
Standard descriptive statistics were used to describe the
study population. Continuous variables were reported as
median (25% to 75% interquartile range, IQR). Univariate
and multivariate analysis using a binary logistic regres-
sion were used to identify factors associated with the
dependent variables (hospital mortality or NIV failure)
[19]. We also carried out analysis of SOFA score exclud-
ing the respiratory component to reduce interaction with
ARDS in the multivariate analysis and to assess the sever-
ity of associated organ failures. Linearity between each
continuous variable and the dependent variable was
demonstrated using locally weighted scatterplot smooth-
ing (LOWESS) [19]. In case of nonlinearity, the variable
was transformed or stratified according to the analysis of
the functional form and clinical significance. For catego-
rical variables with multiple levels, the reference level was
attributed to the one with the lowest probability of the
dependent variable. Variables yielding P-values < 0.2 by
univariate analysis were entered in the multivariate analy-
sis to estimate the independent association of each
covariate with the dependent variable. Results were sum-
marized as odds ratios (OR) and respective 95% confi-
dence intervals (CI). Possible interactions were tested.
Two-tailed P-values < 0.05 were considered statistically
significant.
Results
Characteristics of study population
The study flowchart is shown in Figure 1. A total of 773
patients fulfilled the eligibility criteria of the study and
were therefore evaluated. Their main characteristics are
depicted in Table 1. The most frequent diagnoses at
ICU admission were pneumonia (27%), neurological dis-
eases (19%), non-pulmonary sepsis (12%) and obstruc-
tive pulmonary disease (6%). Patients were admitted to
the ICU at a median of one (zero to three) day after
hospital admission. Median SAPS 3 score was 62 (52 to
72) points and the probability of death estimated by the
global equation was 40 ± 24%. Using the customized
equation for countries from Central and South America,
the probability of death estimated by SAPS 3 was 52 ±
26%. Most patients (67%) used vasopressors during their
stay in the ICU and 19% required renal replacement
therapy (RRT).
Ventilatory support
Invasive MV was initially used in 80% (n = 622) of the
patients and NIV was used in the remaining 20% (n =
151) of the patients as the initial ventilatory support
(Table 1 and Figure 2). Of the later, 81 (54%) patients
failed NIV support and were subsequently intubated for
invasive MV. Ventilatory modes used initially in patients
who received invasive MV were pressure-controlled ven-
tilation (n = 371, 60%), volume-controlled ventilation
(n = 186, 30%), pressure-support ventilation (n = 54,
9%) and others (n = 11, 1%). Median tidal volume was
7.5 (6.1 to 8.7) mL/kg of predicted body weight and pla-
teau pressures were below 30 cmH2O in the vast major-
ity of the patients.
Outcome analysis
The overall ICU and hospital mortality rates were 34% and
42%, respectively (Figure 2 and Table 1). In the univariate
analysis, age, ideal body weight, SOFA score at day 1,
SAPS 3 score, Charlson comorbidity index, hospital length
of stay before ICU, admission from the emergency room
and from the operating room were associated with hospi-
tal mortality. Additionally, NIV failure, lower PaO2/FiO2
ratio, ARDS diagnosis, tracheostomy, duration of ventila-
tory support, need for vasopressors and renal replacement
therapy (RRT), cumulative fluid balance and maximal
blood lactate concentrations were also associated with
hospital mortality (Table 1). In multivariate analysis, older
age, higher SOFA scores (without respiratory component
at Day 1), Charlson comorbidity index > 2, moderate to
severe ARDS, NIV failure, use of invasive MV, higher lac-
tate concentrations and both very negative or positive
cumulative fluid balance over the first 72 hours of ICU
stay were independently associated with increased hospital
mortality (Table 2).
ARDS diagnosis according to the Berlin definition
ARDS was diagnosed in 242 (31%) patients (Figure 2). Of
these, 77% were supported with invasive MV and 23%
received NIV as the initial ventilatory support. The rate of
NIV failure in ARDS patients was 69%, as compared to
45% in non-ARDS patients (P = 0.007). ICU and hospital
mortality in the ARDS population was 46% and 52%,
respectively (Figure 2). In Figure 3, we depicted the ICU
and hospital mortality rates for each category of ARDS.
The combined ICU mortality for ARDS moderate and
severe (the former definition of ARDS [20]) was 55% and
the hospital mortality was 60%.
Non-invasive ventilation characteristics and failure
The characteristics of patients that initially received NIV
are shown in Table 3. The most common diagnoses were
pneumonia (23%), neurologic disorders (21%) and non-
pulmonary sepsis (12%). Classical indications for NIV,
such as obstructive pulmonary disease and congestive
heart failure, were present in only 5% and 8% of the
cases, respectively. NIV failure occurred in 54% (81/151)
of patients receiving NIV initially. Factors related to NIV
failure in univariate analysis were total SOFA score,
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SOFA score excluding respiratory component, ARDS
diagnosis, length of NIV, tracheostomy, use of vasopres-
sors and a positive cumulative fluid balance. As expected,
ICU and hospital lengths of stay and mortality were
higher in patients who experienced NIV failure (Table 3).
In multivariate analysis, a SOFA score without the
respiratory component ≥ 4 points, a diagnosis of ARDS
and a cumulative fluid balance higher than 2 L in the
first 72 hours of ICU stay were associated with NIV fail-
ure (Table 3). The frequency of NIV failure as well as
ICU admissions 
n = 7,465 
 Excluded patients  
n = 5,573 
No use of ventilatory support 
Use of Mechanical 
Ventilation 
n = 1,892 
 Excluded patients  
n = 160 
Missing information 
Triaged Patients 
n = 1,732 
 Study Population 
n = 773 
 Excluded patients  
n = 959 








Figure 1 Flowchart of the study.
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OR (CI 95%) P-value
General
Age - yo 62 (43 to
76)
58 (35 to 72) 69 (53 to 80) 1.03 (1.02 to 1.04) < 0.001
Male gender - n (%) 435 (56) 260 (58) 175 (54) 0.87 (0.66 to 1.17) 0.362
Ideal weight - Kg 61 (52 to
69)
62 (54 to 71) 61 (52 to 67) 0.98 (0.97 to 0.99) 0.034
Admission SAPS 3 score (points) 62 (52 to
72)
58 (49 to 67) 68 (57 to 77) 1.04 (1.03 to 1.06) < 0.001
SOFA score on Day 1 (points) 8 (5 to 10) 7 (4 to 9) 8 (7 to 11) 1.17 (1.12 to 1.23) < 0.001
SOFA score excluding respiratory
component (points)
6 (4 to 8) 5 (3 to 8) 7 (5 to 9) 1.18 (1.13 to 1.24) < 0.001
Charlson Comorbidity Index (points)
0 314 (41) 227 (50) 87 (27) Ref.
1 to 2 288 (37) 160 (36) 128 (40) 0.23 (0.15 to 0.34) < 0.001
> 2 171 (22) 64 (14) 107 (33) 0.48 (0.33 to 0.70)
LOS prior ICU - days 1 (0 to 3) 1 (0 to 2) 1 (0 to 4) 1.03 (1.01 to 1.05) 0.009
Admission source
Ward - n (%) 242 (31) 119 (26) 122 (38) Ref.
Emergency room - n (%) 367 (47) 225 (50) 142 (44) 0.62 (0.45 to 0.86) 0.004
Operation room - n (%) 164 (22) 107 (24) 58 (18) 0.54 (0.36 to 0.81) 0.003
Admission Diagnosis
Pneumonia - n (%) 207 (27) 111 (25) 96 (30) 0.63 (0.32 to 1.23) 0.177
Neurological - n (%) 146 (19) 73 (16) 73 (23) 0.70 (0.41 to 1.22) 0.210
Non-pulmonary sepsis - n (%) 90 (12) 41 (9) 49 (15) 0.77 (0.49 to 1.19) 0.238
Asthma/COPD - n (%) 50 (6) 33 (7) 17 (5) Ref.
Cardiogenic pulmonary edema - n (%) 43 (6) 24 (5) 19 (6) 0.86 (0.42 to 1.75) 0.681
Extracranial trauma - n (%) 41 (5) 24 (5) 17 (5) 1.22 (0.76 to 1.95) 0.415
Hypovolemic/cardiogenic shock - n (%) 37 (5) 23 (5) 14 (4) 0.64 (0.27 to 1.55) 0.326
Aspirative syndromes - n (%) 26 (3) 17 (4) 9 (4) 0.96 (0.48 to 1.92) 0.915
Others - n (%) 133 (17) 73 (16) 60 (18) 0.74 (0.34 to 1.56) 0.431
Comorbidities
Hypertension - n (%) 328 (42) 167 (37) 161 (50) 1.71 (1.28 to 2.29) < 0.001
Diabetes - n (%) 177 (23) 81 (18) 96 (30) 1.95 (1.39 to 2.73) < 0.001
Heart failure - n (%) 67 (9) 27 (6) 40 (12) 2.23 (1.34 to 3.73) 0.002
Chronic renal failure - n (%) 51 (7) 16 (4) 35 (11) 3.32 (1.80 to 6.10) < 0.001
Chronic renal failure in dialysis n (%) 15 (2) 7 (2) 8 (2) 1.62 (0.58 to 4.50) 0.359
Neoplasm - n (%) 162 (21) 66 (15) 96 (30) 1.91 (1.38 to 2.65) < 0.001
AIDS - n (%) 13 (2) 7 (2) 6 (2) 1.21 (0.40 to 3.63) 0.736
COPD - n (%) 80 (10) 47 (10) 33 (10) 0.98 (0.61 to 1.57) 0.938
Ventilatory support category
Successful NIV - n (%) 70 (9) 57 (13) 13 (4) Ref.
NIV failure - n (%) 81 (10) 40 (8) 41 (13) 4.49 (2.14 to 9.45) < 0.001
Invasive MV - n (%) 622 (80) 354 (78) 268 (82) 3.32 (1.78 to 6.19) < 0.001
Respiratory Data at first day
Pressure controlled mode - n (%) 371 (48) 208 (34) 163 (27) 1.09 (0.79 to 1.51) 0.603
Volume controlled mode - n (%) 186 (24) 104 (17) 82 (13) 1.06 (0.75 to 1.49) 0.742
Pressure support mode - n (%) 54 (7) 34 (6) 20 (3) 0.76 (0.42 to 1.35) 0.349
Tidal volume (ideal weight) - mL/kg 7.5 (6.1 to
8.7)
7.3 (6.0 to 8.7) 7.5 (6.6 to 8.9) 1.00 (0.90 to 1.11) 0.992
Plateau pressure - cmH2O 20 (17 to
24)
20 (17 to 24) 20 (16 to 24) 0.99 (0.95 to 1.04) 0.746
PEEP - cmH2O 6 (5 to 8) 6 (5,8) 6 (5 to 8) 0.95 (0.87 to 1.03) 0.206
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hospital mortality increased significantly with the number
of these risk factors presented by the patients (Figure 4).
Weaning and tracheostomy
Table 4 depicts the variables related to weaning in our
population. Carrying out a spontaneous breathing trial
and a successful extubation were protective factors for
mortality in the univariate analysis. Additionally, 30% of
the patients that were successfully extubated received
non-invasive ventilation after extubation. Weaning fail-
ure with subsequent reintubation occurred in 15% of
the patients. Tracheostomy was carried out in 182 (29%)
patients under invasive mechanical ventilation 7 (5 to
11) days after endotracheal intubation.
Discussion
In the present study, mortality rates of patients in Brazilian
ICUs requiring ventilatory support were elevated, regard-
less of the underlying condition. Factors such as age,
comorbidities, ARDS, disease severity and variables related
to ICU support like positive fluid balance and NIV failure
are independently associated with hospital mortality. We
also observed that more than half of the patients receiving
NIV as the primary modality of ventilatory support failed
and required invasive mechanical ventilation subsequently.
Variables independently associated with NIV failure were
the severity of organ dysfunctions, the presence of ARDS
and a positive fluid balance.
The mortality rate of critically ill patients under ventila-
tory support and patients with ARDS is elevated in both
observational and interventional studies [6,21,22]. In the
last decade, however, important ventilatory interventions,
such as lung protective strategies with reduction in tidal
volumes [3] and widespread use of NIV [23], were more
frequently incorporated in the clinical practice [24] and
could have resulted in different mortality rates. Neverthe-
less, some recent studies showed very modest or no
changes in these outcomes [2,4,9,25]. In a systematic
review by Phua et al., the pooled mortality rate of ARDS
in observational studies was 48% and did not decrease sig-
nificantly in the last years [26]. More recently, Villar et al.
reported a hospital mortality rate of 48% for ARDS
patients under low tidal volume ventilation [4]. We
observed a higher mortality rate for the entire cohort and
a more prominent rate for ARDS patients. However, our
results are within the predicted mortality range of SAPS 3
and comparable to those reported in similar countries,
such as Argentina [27]. Possible explanations for our find-
ings may include unequal access to healthcare [28,29] as
well as unmeasured factors related to the process of caring
for these patients.
There is a significant gap between the recommenda-
tions of low tidal volumes for ARDS patients and their
adoption in practice. Several observational studies
demonstrated the lack of adherence to this strategy [9,30]
and our study confirms these findings. Moreover, a
recent meta-analysis suggests that even ventilated
patients without ARDS may benefit from low tidal
volumes [31]. However, it is important also to emphasize
that in this trial and similar to other studies, the majority
of patients were ventilated with plateau pressures below
the limit of 30 cmH20, which may partially compensate
the harmful effects of high tidal volumes.
In our study, more than 60% of the patients under inva-
sive MV for more than 24 hours were submitted to a spon-
taneous breathing trial and 54% were extubated, which is
similar to previous reports [32]. Seventeen percent of the
patients used NIV after extubation, an incidence also
Table 1 Patients?’? characteristics and univariate analysis of factors associated with hospital mortality (Continued)
PaO2/FiO2 ratio 257 (185 to
330)
260 (196 to 346) 250 (167 to 316) 0.99 (0.99 to 1.00) 0.014
ARDS - n (%) 242 (31) 116 (26) 126 (39) 1.50 (1.06 to 2.12) 0.021
Length of ventilatory support - days 5 (3 to 10) 5 (2 to 8) 6 (3 to 12) 1.02 (1.01 to 1.04) 0.005
Support during ICU stay
RRT - n (%) 148 (19) 47 (10) 101 (31) 3.91 (2.67 to 5.75) < 0.001
Vasopressors - n (%) 521 (67) 265 (60) 256 (79) 2.83 (2.02 to 3.98) < 0.001
Cumulative fluid balance (72 h) - L 2.9 (0.8 to
5.4)
2.6 (0.8 to 4.6) 3.7 (1.1 to 6.2) 1.05 (1.01 to 1.10) 0.011
Outcomes
ICU mortality - n (%) 260 (34) ————————— ————————— ————————— ————————
Hospital mortality - n (%) 322 (42) ————————— ————————— ————————— ————————
ICU LOS - days 10 (6 to 18) 10 (6 to 17) 10 (5 to 19) 1.01 (1.00 to 1.02) 0.047
Hospital LOS - days 20 (11 to
34)
23 (14 to 36) 16 (7 to 30) 0.99 (0.98 to 0.99) 0.009
Abbreviations: AIDS, Acquired Immunodeficiency Syndrome; ARDS, Acute Respiratory Distress Syndrome; COPD, Chronic Obstructive Pulmonary Disease; ICU,
Intensive care unit; LOS, Length-of-stay; MV, Mechanical ventilation; NIV, Non-invasive ventilation; PEEP, Positive End-Expiratory Pressure; RRT, Renal Replacement
Therapy; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment.
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comparable to other studies [33]. Tracheostomy was done
in 29% percent of the patients in a median period of one
week after initiation of MV. There is significant heteroge-
neity in the rates of tracheostomy in patients under MV as
well as at the time of the procedure [9,34-36]. A previous
one-day point-prevalence study of MV that included
patients from Brazil showed that tracheostomy was done
in 27% of the individuals in a median of 8 (1 to 15) days
after ventilatory support [12]. These numbers are similar to
our report and to comparable countries such as Argentina,
Chile and Uruguay [12].
NIV was used as the first line of treatment for respira-
tory failure in 20% of the patients in our population, with
a 54% failure rate. The failure rates for NIV are quite vari-
able in the literature and seem to be related to the cause
of respiratory failure and disease severity [23,37,38]. Ele-
vated failure rates are worrisome since NIV failure has
been previously associated with increased mortality risk
[39] and, in this study, was an independent risk factor for
mortality. We could speculate that misperception of
disease severity by the multidisciplinary team may have
contributed to over-utilization of NIV for high-risk
patients, delaying invasive mechanical ventilation and con-
tributing to the poor outcome of these patients.
Another example of a potentially modifiable risk factor
for mortality is related to the fluid strategy. A positive
fluid balance is consistently associated with adverse out-
comes in the ICU setting, mainly for patients with ARDS
[40,41] and acute kidney injury [42]. We found that the
extremes of cumulative fluid balance in the first three days
are independently associated with hospital mortality. Inter-
estingly, we also found that a positive fluid balance in the
first days was associated with NIV failure. Our data sug-
gest that, taking into account the hemodynamic status, a
judicious fluid balance in the first days of ICU stay may be
a safer goal in patients under ventilatory support.
The present study has several shortcomings. First, it was
carried out during the winter period in the Southern
hemisphere, and this may have influenced the incidence of















































Figure 2 ICU and hospital mortality rates according to ventilatory support, ARDS diagnosis and NIV failure. ARDS, acute respiratory
distress syndrome; ICU, intensive care unit; MV, mechanical ventilation.
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Table 2 Factors associated with hospital mortality in a multivariate analysis
Parameter OR CI 95% P-value
Age 1.03 1.01 to 1.03 < 0.001
SOFA Score excluding respiratory component 1.12 1.05 to 1.19 < 0.001
Charlson comorbidity index 0.002
0 ref ref
1 to 2 1.37 0.92 to 2.04 0.124
> 2 2.30 1.28 to 3.17 < 0.001
ARDS 0.037
Absence ARDS ref ref
ARDS mild 1.09 0.68 to 1.73 0.721
ARDS moderate 1.92 1.11 to 3.35 0.02
ARDS severe 2.12 1.02 to 4.41 0.045
Mechanical ventilation 0.004
Successful NIV ref ref
NIV failure 3.96 1.74 to 8.99 0.001
Invasive MV 2.67 1.32 to 5.39 0.006
Cumulative fluid balance (72 h) 0.005
< -1.5 L 3.08 1.47 to 6.48 0.003
-1.5 L to +1.5 L ref ref
> +1.5 L to +5.0 L 1.84 1.11 to 3.04 0.018
> 5.0 L 2.44 1.39 to 4.28 0.002
Lactate levels (Ln + 0.5) 1.78 1.27 to 2.51 0.001
Abbreviations: ARDS, Acute Respiratory Distress Syndrome; MV, Mechanical ventilation; NIV, Non-invasive ventilation; SOFA, Sequential Organ Failure Assessment
Score. Area under receiver operating curve for predicted mortality (95% CI): 0.77 (0.73 to 0.81), P < 0.001. Hosmer-Lemeshow Χ2: 8.535, P = 0.383.
























Figure 3 ICU and hospital mortality rates according to the Berlin definition of ARDS. P < 0.001 (Pearson Chi-square test) for the
comparison of hospital mortality and ARDS classification. ARDS, acute respiratory distress syndrome; ICU, intensive care unit.
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However, the study was conducted between early June and
the end of July and epidemiologic data demonstrate that
both Influenza and other lower respiratory infections pre-
sent a different seasonality varying according to the region
of the country [43]. We did not collect data on the origin
and on the time of ARDS development, which precludes a
more detailed evaluation of these patients. In addition, we
used a convenience sample of ICUs that usually participate
in clinical studies in Brazil and the sites that included
patients are predominantly from the Southeast and South-
ern regions of the country, thus our data may not be
representative of the entire nation. However, the concen-
tration of hospitals from these regions is in accordance
with a higher concentration of ICU beds and the health-
care system in Brazil [44]. Considering that academic insti-
tutions and those participating in clinical studies usually
Table 3 Factors associated with NIV failure on univariate and multivariate analysis







OR (CI 95%) P-value
(multivariate)
General
Age - yo 63 (48 to 80) 67 (43 to 78) 0.826
Male gender - n (%) 34 (49) 45 (56) 0.392
Admission SAPS 3 Score (points) 59 (50 to 68) 62 (55 to 69) 0.180
SOFA Score on Day 1 (points) 5 (3 to 7) 7 (4 to 8) < 0.001
SOFA Score excluding respiratory component (points) 3 (1 to 5) 4 (4 to 7) 0.001
SOFA excluding respiratory component ≥ 4 points 34 (48) 65 (80) < 0.001 1.20 (1.05 to 1.34) 0.009
Charlson Comorbidity Index (points)
0 21 (30) 25 (31) Ref
1 to 2 32 (46) 38 (47) 0.794
> 2 17 (24) 18 (22) 0.782
Admission diagnoses 0.562
Pneumonia - n (%) 17 (24) 18 (22)
Neurological - n (%) 13 (19) 19 (23)
Non-pulmonary sepsis - n (%) 9 (13) 10 (12)
Asthma/COPD - n (%) 4 (6) 3 (4)
Cardiogenic pulmonary edema - n (%) 5 (7) 7 (9)
Extracranial trauma - n (%) 4 (6) 2 (3)
Hypovolemic/cardiogenic shock - n (%) 5 (7) 5 (6)
Aspirative syndromes - n (%) 4 (7) 3 (4)
Others - n (%) 9 (13) 14 (17)
Respiratory data
Inspiratory pressure first day - cmH2O 12 (10 to 15) 12 (11 to 15) 0.956
Expiratory pressure first day - cmH2O 8 (8 to 10) 8 (6 to 10) 0.891
PaO2/FiO2 ratio first day 230 (185 to 300) 200 (150 to 300) 0.271
ARDS - n (%) 17 (31) 38 (69) 0.004 2.31 (1.10 to 4.82) 0.026
Length of NIV - days 3 (2 to 4) 1 (0 to 2) < 0.001
Day of NIV failure — 1 (0 to 2) —
Tracheostomy - n (%) 2 (3) 16 (20) 0.007
ICU variables
Vasopressors - n (%) 16 (23) 50 (62) < 0.001
Cumulative fluid balance ≥ 2 L (72 h) - n (%) 36 (51) 59 (73) 0.007 2.09 (1.02 to 4.30) 0.045
Outcome
ICU mortality - n (%) 7 (10) 38 (47) < 0.001
Hospital Mortality - n (%) 13 (19) 41 (51) < 0.001
ICU LOS - days 7 (4 to 8) 13 (7 to 23) < 0.001
Hospital LOS - days 14 (9 to 26) 21 (13 to 30) 0.071
Data are expressed as median (p25 to p75) or number (%). Abbreviations: ARDS, Acute Respiratory Distress Syndrome; COPD, Chronic Obstructive Pulmonary
Disease; LOS, Length-of-stay; NIV, Non-invasive ventilation; RRT, Renal Replacement Therapy; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ
Failure Assessment. Area under receiver operating curve for NIV failure (95% CI): 0.72 (0.64 to 0.80), P < 0.001. Hosmer-Lemeshow Χ2: 2.555, P = 0.768.
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Figure 4 Interaction of risk factors for failure of non-invasive ventilation and hospital mortality. Fluid balance denotes cumulative fluid
balance ≥ 2 L in the first 72 hours of intensive care unit stay. SOFA score denotes Sequential Organ Failure Assessment punctuation ≥ 4
(excluding respiratory component). ARDS denotes Acute Respiratory Distress Syndrome. P < 0.001 (Pearson Chi-square test) for both the
comparisons of hospital mortality and non-invasive ventilation failure and risk factors interaction.







OR (CI 95%) P-value
General variables - n (%)
Successful spontaneous breathing trial 378 (61) 304 (86) 74 (28) 0.06 (0.04 to 0.09) < 0.001
Extubation 338 (54) 270 (76) 68 (25) 0.11 (0.08 to 0.16) < 0.001
Use of NIV after extubation 108 (17) 77 (22) 31 (12) 0.52 (0.34 to 0.83) 0.006
Reintubation 94 (15) 57 (16) 37 (14) 0.94 (0.59 to 1.47) 0.792
Time to reintubation 1 (0 to 3) 1 (0 to 3) 1 (0 to 3) 1.00 (0.94 to 1.07) 0.837
Time < 48 hours to reintubation 57 (9) 30 (8) 27 (10) 0.74 (0.38 to 1.47) 0.400
Tracheostomy 182 (29) 93 (26) 89 (33) 1.37 (0.97 to 1.39) 0.073
Days to tracheostomy 7 (5 to 11) 7 (5 to 10) 9 (6 to 12) 1.04 (0.99 to 1.10) 0.057
Cause of extubation failure (more than one may apply) - n (%)
Coma 41 (6) 14 (4) 27 (10) 3.06 (1.57 to 5.97) < 0.001
Agitation/delirium 11 (2) 8 (2) 3 (1) 0.54 (0.14 to 2.06) 0.371
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have better organization and standards of care, it is possi-
ble that the actual mortality of mechanically ventilated
patients may be even higher.
Conclusions
Current mortality of mechanically ventilated patients in
Brazil remains elevated. Implementation of judicious fluid
therapy and a watchful use and monitoring of NIV patients
are potential targets to improve outcomes in this setting.
Key messages
• Contemporary information on mechanical ventila-
tion use in emerging countries is limited. Moreover,
most epidemiological studies on ventilatory support
were carried out before significant developments,
such as lung protective ventilation or widespread
application of non-invasive ventilation.
• In mechanically ventilated patients in Brazil, fac-
tors such as age, comorbidities, ARDS, disease sever-
ity and variables related to ICU support, such as
positive fluid balance and NIV failure, are indepen-
dently related to hospital mortality.
• NIV failure occurred in 54% of the patients and
was associated with the severity of organ dysfunc-
tions, presence of ARDS and positive fluid balance.
• Current mortality of ventilated patients in Brazil is
exceedingly high. Implementation of judicious fluid
therapy and a watchful use and monitoring of NIV
patients are potential targets to improve outcomes
in this setting.
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